Ph.D., 2009, Univ. of California, Berkley
We are interested in dissecting the distinct functions of synaptic cell-adhesion molecules implicated in neuropsychiatric disorders and addiction in the context of disease-relevant brain circuits. Using cutting-edge multidisciplinary techniques, we are able to interrogate these molecules with cell-type and synapse-specific resolution.
Ph.D., 2009, Columbia University
Molecular Mechanisms of ion channel function. Examining structural and regulatory mechanisms of the Acid-sensing ion channels using electrophysiology, fluorescence, spectroscopy, and structural biology.
Bayer, K. Ulrich
Ph.D., 1996, Heinrich-Pette-Institute
Molecular mechanisms of synaptic plasticity. Strategies for restoring normal synaptic plasticity in neurological disorders.
Caino, M. Cecilia
Ph.D., 2010, Univ. de Buenos Aires
Our group aims to understand how mitochondria reprogramming in tumors impact cellular behaviors that drive progressive and lethal cancer. We use a broad repertoire of biochemistry, cell biology, live cell imaging and animal models to study the impact of mitochondria shape, number and subcellular distribution in metastatic dissemination.
Churchill, Mair E. A.
Ph.D., 1987, Johns Hopkins Univ.
Structure and mechanism in gene regulation; biophysical and structural studies of protein-nucleic acid and protein-protein complexes in chromatin and bacterial pathogenesis.
Ph.D., University of Bordeaux Segalen, France
The control of cerebral blood flow by ion channels and calcium signaling in the pericytes, endothelial cells, and smooth muscle cells that constitute the brain microcirculation. We use this information to combat brain diseases with a vascular component.
Dell'Acqua, Mark L.
Professor and Vice Chairman
Ph.D., 1995, Harvard Univ.
Organization of signaling complexes by protein kinase and phosphatase anchoring proteins; mechanisms regulating neuronal second messenger signaling in synaptic plasticity.
Edelstein, Charles L.
Professor of Medicine
MD, Ph.D., FAHA, FASN
Caspases and apoptosis in PKD
Ph.D., 2003, Univ. of Alberta
We study the synaptic mechanisms by which neuromodulators like dopamine and acetylcholine are encoded in mesolimbic and nigrostriatal circuits through their G-protein coupled receptors and the alterations that occur in these systems in neurological and psychiatric diseases.
Ford, Heide, L.
Ph.D., 1995, Univ. of Rochester
My laboratory studies the parallels between normal development and tumorigenesis/metastasis with a focus on the role of the Six1/Eya transcriptional complex in TGF-beta signaling, epithelial to mesenchymal transition, cancer stem cells, and metastasis.
Heasley, Lynn E.
Ph.D., 1985, Univ. of California, San Diego
Investigating the role of MAP kinases and specific receptor tyrosine kinases in normal and transformed growth of lung epithelial cells using techniques of molecular and cell biology in lung epithelial cells and human lung cancer cell lines.
Professor of Medicine
MD, 2000, University of Heidelberg
Pulmonary hypertension, right heart failure, sex differences in cardiopulmonary disease, estrogen signaling in the lung and right ventricle, angiogenesis and endothelial cell function in pulmonary vascular disease and right heart failure, hypoxia-induced cardiac and lung vascular remodeling, neurohormonal signaling in right heart failure, androgen signaling in asthma.
McKinsey, Timothy A.
Ph.D., 1998, Vanderbilt Univ.
Epigenetic regulation of heart failure; signaling and transcriptional mechanisms of muscle disease.
Ph.D., 1977, Cornell Univ.
Signaling pathways controlling growth and differentiation of vascular smooth muscle cells; Role of eicosanoids in lung cancer.
Port, J. David
PhD, 1989, Univ. of Utah
G-protein linked receptors and their regulation; regulation of mRNA stability.
Ph.D., 2010, Oregon Health & Sciences University
Our research is focused on excitability and plasticity changes in the brain following ischemic insults such as cardiac arrest and stroke.
Schweppe, Rebecca E.
Ph.D., 2000, University of Colorado Health Sciences Center
The focus of my lab is to identify novel molecular targets relevant to papillary and anaplastic thyroid cancer (PTC and ATC) with the ultimate goal of advancing these studies to clinical trials for thyroid cancer patients who do not respond to standard treatments.
Tucker, Chandra L.
Ph.D., 1999, Univ. of Washington
Protein engineering and optogenetics, Development of novel tools to sense and manipulate the intracellular environment.
Weiser-Evans, Mary C.M.
Ph.D., 1992, Colorado State Univ.
Defining the molecular signaling mechanisms regulating vascular smooth muscle cell function in the setting of vascular fibroproliferative diseases, including restenosis and pulmonary hypertension.